Intrinsic Value of S&P & Nasdaq Contact Us

Verve Therapeutics, Inc. VERV

NASDAQ Global Select

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+34.8%

Verve Therapeutics, Inc. (VERV) current share price is $11.13. The gold spot price is $4,808.10 per troy ounce. Using the formula: VERV in gold = $11.13 × 31.1035 ÷ $4,808.10 = 0.0720 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of VERV when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding VERV shares over the measured period.

VERV in US Dollars
Gold in US Dollars
VERV in Gold (grams per share)

Real Wealth Growth Rate

VERV
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{VERV}_{\text{gold}}(t) = \frac{P_{\text{VERV}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{VERV}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{VERV}_{\text{gold}}^{(T)}}{\text{VERV}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{VERV}_\text{gold}^{(0)}$ = initial gold-price, $\text{VERV}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
CRSP
CRSP
CRISPR Therapeutics AG
$56.86
+3.70%
BEAM
BEAM
Beam Therapeutics Inc.
$30.30
+0.40%
RLAY
RLAY
Relay Therapeutics, Inc.
$14.75
-3.34%
ADPT
ADPT
Adaptive Biotechnologies Corporation
$14.53
+2.83%
NTLA
NTLA
Intellia Therapeutics, Inc.
$14.78
+3.65%
SANA
SANA
Sana Biotechnology, Inc.
$3.48
+8.41%
LIFE
LIFE
aTyr Pharma, Inc.
$14.69
+2.23%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message